Effective Marketing for Healthcare Companies

Ready to See Results?

From strategy to execution, we turn underperforming campaigns into measurable wins. Let’s put our expertise to work for your business.

Key Takeaways

Defensible admissions growth depends on integrating substantiated claims architecture, PHI-aware audience design, and outcome-linked measurement into one governance system spanning HIPAA, FTC, SAMHSA, and 42 CFR Part 2 ^{4, 6, 9}.
Audience design hinges on whether data is pre-relationship or part of a clinical record, since standard lookalikes and retargeting pixels often fail HIPAA and Part 2 requirements without specific authorization ^{4, 6}.
Reporting should shift from impressions and clicks to access, experience, and outcome metrics, with cost per admission by service line driving budget decisions rather than cost per call ².
For multi-facility portfolios, segment budgets by level of care using internal call-to-admit and census data, and diagnose intake gaps before adding spend to leaky funnels ^{2, 9}.

The Operating Model Behind Defensible Admissions Growth

Behavioral health marketing has diverged. One approach uses a rigorous, measurement-driven demand engine directly linked to admissions. The other relies on campaign-specific tactics without fully addressing compliance with HIPAA, FTC substantiation rules, SAMHSA guidance, and 42 CFR Part 2 ^{4, 6, 9}. This disparity impacts cost per admission, census stability, and the frequency of legal review delays.

Sustainable admissions growth now requires integrating three key areas: substantiated claims architecture, PHI-aware audience design, and outcome-linked measurement. When these are managed as a unified operating system, they streamline the path from inquiry to admission while ensuring the organization can defend its claims and data usage to regulators, payers, or accreditation surveyors ^{2, 9}.

This article details this operating system, covering evolving patient digital expectations, the application of a consolidated governance layer to various marketing assets (ad copy, landing pages, retargeting, testimonials, lead forms), and how to shift from impression-based reporting to the access, experience, and outcome metrics outlined in the 2024 Patient Engagement Impact Measurement Framework ². A subsequent section will explore portfolio admissions economics for leaders managing multiple facilities or service lines, where demand dynamics for MAT, IOP, PHP, and residential programs differ.

Why Digital Expectations Hardened Around Behavioral Health

Prospective patients and their families approach behavioral health admissions with digital expectations shaped by their experiences with acute care. An HHS/ONC data brief from 2024 indicated that 80% of U.S. hospitals offered fundamental patient engagement features like secure messaging and record access, with 67% providing advanced capabilities such as access to clinical notes ¹. While this brief focuses on acute care, these benchmarks influence expectations for addiction treatment centers and behavioral health systems.

When individuals research treatment options, their digital history includes interactions with hospital portals, telehealth platforms, and pharmacy apps. This means treatment centers are competing against a high standard of digital interaction, often set by organizations with significant IT budgets ¹.

This shift has three operational implications:

Speed: Families accustomed to rapid responses from primary care providers will not tolerate lengthy callbacks from intake departments.
Transparency: Patients who can view their own clinical notes expect detailed information about levels of care—including schedules, staff credentials, daily routines, and accepted insurance—before making initial contact.
Form factor: Secure messaging, scheduling widgets, and structured intake forms are now expected features, not competitive advantages.

These expectations do not negate regulatory requirements. Faster responses must still use HIPAA-authorized channels, and transparent program descriptions require FTC-grade substantiation. However, marketers who view digital expectations as a relic of the past will struggle to compete in the current landscape. The admissions funnel now often begins digitally, days before a call, and the quality of this pre-call experience significantly influences whether a call occurs at all.

Infographic showing US Hospitals with Foundational Health IT Patient Engagement Capabilities — US Hospitals with Foundational Health IT Patient Engagement Capabilities

The Consolidated Governance Layer

Claims Architecture Under FTC Substantiation

Regulators prioritize claims. The Federal Trade Commission’s December 2022 Health Products Compliance Guidance extended its substantiation framework to cover all health-related products and services, including digital health tools and service offerings ⁹. This expansion means every outcome claim, success rate, completion statistic, and efficacy comparison on a treatment center’s website is now subject to this rigorous standard.

Increased scrutiny on addiction treatment marketing was foreshadowed by a 2017 U.S. House subcommittee hearing that addressed deceptive advertising practices in the substance use treatment industry. Testimony at this hearing advocated for applying FTC truth-in-advertising standards to misleading claims targeting vulnerable individuals ⁵. Regulatory enforcement in this sector has remained stringent since.

Operationally, claims architecture for behavioral health sites involves three key aspects:

Outcome claims, such as recovery rates or sobriety durations, must be supported by competent and reliable scientific evidence. The FTC defines this as testing, analysis, or research conducted by qualified individuals using generally accepted procedures in the field ⁹. Internal CRM data, without disclosed methodology, typically does not meet this standard.
Treatment efficacy language, including terms like “proven” or “evidence-based,” must be specifically linked to the described modality. For example, Medication-Assisted Treatment (MAT) has a strong evidence base, while a proprietary group therapy curriculum may not.
Digital health tool claims, such as promises about app-based recovery support or telehealth efficacy, are subject to the same FTC substantiation rules as physical products ⁹. Marketers who assume digital tools are exempt due to their software nature are misinterpreting the 2022 guidance.

An effective claims architecture involves documenting the evidence for every public claim, version-controlling landing page copy against this evidence, and routing new outcome statements through a single review process before paid promotion.

PHI-Aware Audience Design and the Narrow Marketing Exceptions

The HIPAA Privacy Rule generally requires written authorization for most uses or disclosures of protected health information (PHI) for marketing purposes ^{6, 7}. The exceptions are specific and critical for audience design.

Three exceptions exist: face-to-face communications between a covered entity and an individual, promotional gifts of nominal value, and communications about the provider’s own health-related products or services, including treatment and care coordination ^{6, 10}. Any activity outside these exceptions—such as building a custom audience from an EHR export or using former patient phone numbers for lookalike models—requires authorization to avoid a violation.

This constraint significantly redefines audience design:

First-party data from prospective patients who have not yet received care is not considered PHI under HIPAA. However, it becomes PHI once integrated into a clinical record. For instance, a web form capturing interest in MAT before a treatment relationship exists is outside the rule, but the same data linked to an active patient chart falls within it. The distinction lies in the relationship, not the data field itself.

Authorizations, when obtained, must be specific. A general consent in admissions paperwork does not permit using PHI for third-party advertising platforms. HHS guidance explicitly states that authorizations must detail the information to be used, its purpose, and the recipient ⁶.

Consequently, retail marketing audience strategies are often inapplicable. Building a lookalike audience from converted patients without authorization is not a gray area. Sending a discharge follow-up email promoting a sister facility’s services to a former patient, without authorization, is considered marketing under the rule unless it pertains to the provider’s own services ^{6, 10}.

The key design question becomes: which audiences can be created from pre-relationship data, which necessitate authorization, and which are entirely prohibited? Establishing clear guidelines for this prevents repetitive rework and reduces cost per admission.

42 CFR Part 2, Testimonials, and Retargeting Pixels

42 CFR Part 2 imposes additional restrictions beyond HIPAA, specifically for federally assisted substance use disorder (SUD) treatment programs. SAMHSA’s regulatory hub provides comprehensive guidance, with Part 2 being central to marketing implications ⁴. This rule limits the disclosure of any information that could identify an individual as having sought or received SUD treatment, offering stricter confidentiality than HIPAA.

Three marketing elements frequently conflict with Part 2:

Patient testimonials: A HIPAA-compliant authorization is insufficient for a Part 2 program. Part 2 consent forms require specific elements, as a testimonial identifying someone as a patient of a Part 2 program constitutes a disclosure of protected information ⁴. Video testimonials, named case studies, and “meet our alumni” pages all require Part 2-compliant consent, not just a standard media release.
Retargeting pixels: A pixel on a Part 2 program’s site can transmit information to an ad platform, indicating a visitor’s interest in SUD treatment. Even for non-patients, pixel-based audience building on URLs clearly identifying SUD services creates disclosure risks ⁴. Many operators now use server-side tagging with stripped identifiers or implement placement strategies that exclude pages detailing specific levels of care.
Lead-form trackers: Data submitted via a SUD treatment landing page, when combined with third-party analytics or call-tracking vendors lacking Business Associate Agreements (BAAs) specifically scoped to Part 2, creates similar exposure. A standard BAA covers HIPAA but does not automatically cover Part 2 unless explicitly stated in the contract.

The solution is structural. Every tag, form vendor, and testimonial must be audited against Part 2 consent and BAA requirements before new SUD-specific landing pages are launched.

Accreditation Language and Endorsement Boundaries

Joint Commission accreditation serves as a valid quality indicator, with StatPearls noting that TJC maintains standardized quality measures and safety standards for accredited organizations, including in behavioral health ³. The marketing challenge lies in accurately representing this status.

Accredited status is a factual and citable claim. Performance on specific TJC quality measures, if supported by underlying data, is also citable. However, language implying endorsement of a particular treatment approach, clinical outcome, or marketing program by the accrediting body crosses the line. Similar caution applies to federal agencies; HHS has issued warnings against misleading marketing claims that suggest government endorsement of compliance programs, clarifying that such endorsements are not granted ⁸.

Practical guidelines for external messaging include stating accreditation as a fact with a date. Avoid pairing accreditation logos with outcome claims in the same visual frame, as this suggests the accrediting body validated those outcomes. Describe a program as “accredited by The Joint Commission” rather than “Joint Commission approved.” Furthermore, do not present a compliance vendor’s marketing materials on a public site in a way that implies HHS endorsement of their product ^{3, 8}.

The same governance review process used for FTC claims and HIPAA authorization should also approve accreditation and endorsement language, ensuring consistency and compliance.

Visualize the four-part governance framework (FTC claims, HIPAA PHI rules, 42 CFR Part 2, accreditation language) that the section's subsections describe as a single operating system

Outcome-Linked Measurement Beyond Impressions

Impressions, clicks, sessions, and form fills do not provide a CFO with information about marketing’s impact on admissions. The 2024 Patient Engagement Impact Measurement Framework, a peer-reviewed work designed to standardize the evaluation of engagement initiatives across healthcare, organizes measurement into three layers: access, experience, and clinical outcomes ². While not specifically for marketers, this framework aligns well with a behavioral health admissions funnel and can replace superficial reporting in budget discussions.

Access metrics: Track the ability of individuals to reach care. In behavioral health, this includes time-to-first-response for inquiries, percentage of after-hours calls answered live, average days from inquiry to scheduled assessment, and percentage of leads contacted within the first hour. These are directly influenced by marketing efforts such as budget allocation, landing page design, call routing, and chat coverage.
Experience metrics: Evaluate the quality of interaction for prospective patients or families. Examples include call recordings scored against an intake quality rubric, drop-off rates at each stage of digital intake forms, Net Promoter or CSAT scores from families who completed an assessment (even if they didn’t admit), and mystery-shopper calls to assess consistency across service lines. These metrics reveal where qualified demand is lost due to factors unrelated to ad performance.
Outcome metrics: Complete the loop. The framework identifies clinical outcomes as the ultimate measure of engagement value ². For a VP seeking budget approval, operational outcome metrics include call-to-admit rates by service line, admit-to-completion rates, length of stay compared to clinical benchmarks, and post-discharge engagement with alumni or step-down programs. While not traditional marketing metrics, they determine the value of the cost per qualified call.

Two reporting changes are necessary:

Dashboards should prioritize qualified calls by source, call-to-admit rates by source, and cost per admission by source, rather than impressions and CPC. Channel reports should become outcome reports.
The attribution model must bridge the gap between a click and a clinical record, a common failure point in behavioral health measurement. Essential infrastructure includes call tracking with dynamic number insertion, CRM integration that captures source for every inquiry, and a closed-loop process that updates marketing platforms with admit status. Without this loop, the access and experience layers become disconnected from outcomes, leading to superficial reporting ².

Data-Driven Marketing Solutions for Healthcare Growth

Leverage research-backed digital marketing strategies to efficiently reach patients at critical decision points and drive measurable admissions growth across your healthcare service lines.

Optimize Patient Reach

Service-Line Demand: MAT, IOP, PHP, and Residential

Demand patterns vary significantly across different levels of care. A uniform content strategy for MAT, IOP, PHP, and residential programs will likely underperform in at least three of these areas.

MAT inquiries often focus on immediate needs and logistics. Prospective patients seek information on buprenorphine or methadone availability, same-week induction, dosing schedules, and telehealth follow-up. The strong clinical evidence for medication treatment allows for efficacy claims under FTC substantiation standards when linked to specific medications and protocols ⁹. SAMHSA’s regulatory guidance for Opioid Treatment Programs (OTPs) dictates how services are described, and misleading ad copy or omitted disclosures can lead to scrutiny ⁴.
IOP demand typically comes from individuals balancing work or school, who are comparing schedules and modalities. Landing pages that display actual weekly schedules, group topics, and evening or virtual options are more effective than those using general brand language. The primary qualifying factor is usually program fit, not crisis.
PHP attracts a more specific audience, often individuals transitioning from residential care or stepping up from outpatient services, frequently coordinating with a referring clinician. In many markets, referral relationships and clinician-focused content generate more PHP volume than direct consumer searches.
Residential care has the highest acquisition cost and the longest decision-making process, with families often conducting extensive research. Transparency regarding length of stay, daily structure, family programming, and aftercare planning can shorten this window, while vague promises prolong it.

The operational implication is that budget, creative content, and intake scripts should be segmented by level of care, rather than being pooled.

If You Manage Multiple Facilities: Portfolio Admissions Economics

For leaders managing a portfolio of facilities, levels of care, or state markets, the financial models that apply to a single IOP or residential program do not directly scale across a network.

At the portfolio level, three patterns emerge: cost per qualified call varies by service line and market; call-to-admit rates differ by intake team and lead quality; and census contribution per service line fluctuates monthly due to referral patterns, payer mix, and clinical capacity. A single network-wide cost-per-admission figure averages these variables, obscuring where budget is truly effective.

Service Line	Monthly Qualified Calls	Call-to-Admit Rate	Cost per Qualified Call	Implied Cost per Admission	Census Contribution
MAT	[your data]	[your data]	[your data]	Cost per call ÷ call-to-admit rate	Admits × avg length of engagement
IOP	[your data]	[your data]	[your data]	Cost per call ÷ call-to-admit rate	Admits × avg weeks in program
PHP	[your data]	[your data]	[your data]	Cost per call ÷ call-to-admit rate	Admits × avg weeks in program
Residential	[your data]	[your data]	[your data]	Cost per call ÷ call-to-admit rate	Admits × avg length of stay

Once the worksheet is complete, two operational actions follow:

Reallocate budget based on implied cost per admission, not cost per call. For example, a service line with a $200 cost per qualified call and a 40% call-to-admit rate yields admissions at $500 each. Conversely, a service line with a $90 cost per qualified call but an 8% call-to-admit rate results in admissions costing $1,125 each. The seemingly cheaper channel can be the more expensive admission source.
Diagnose call-to-admit gaps before increasing spending. A low call-to-admit rate despite high call volume indicates an intake problem, not a marketing deficiency. Increasing budget for a leaky funnel will only raise the portfolio’s cost per admission. The access and experience metrics discussed earlier—such as time-to-first-response, intake quality scores, and drop-off rates—are crucial for this diagnosis ².

Where Marketing Operations Usually Break

Failure points in marketing operations are often predictable and tend to occur in similar areas across organizations of varying sizes, typically stemming from operational rather than strategic issues.

The first is claims drift. An initial landing page may launch with a thoroughly vetted outcome statistic. Months later, a paid social ad might reuse this statistic with rounded numbers or stronger verbs, without the original evidence file accompanying it. When the FTC substantiation standard is applied retroactively, the ad copy fails, even if the source page would have passed ⁹.
The second is consent decay. An authorization signed at intake covers the specific use described at that time. It does not automatically extend to new advertising platforms, audience types, or promotions for sister facilities added later ⁶. Organizations that build audiences once and reuse them for years accumulate compliance risks that often go unmonitored.
The third is vendor sprawl. Call-tracking platforms, chat widgets, form builders, and analytics tags are often added by different teams across various facilities. Each of these can become a potential disclosure pathway under 42 CFR Part 2 if Business Associate Agreements (BAAs) are not correctly scoped ⁴. A quarterly tag audit, conducted against a current vendor inventory, can identify these gaps before a breach occurs.
The fourth is the measurement gap between marketing and intake. Marketing typically reports on calls, while intake reports on admissions. If these two systems do not share a common source field, calculating cost per admission by channel becomes impossible, leading to budget decisions based solely on cost per call ². Closing this loop represents the most impactful operational fix for most VPs.

Infographic showing US Hospitals with Emerging Health IT Patient Engagement Capabilities — US Hospitals with Emerging Health IT Patient Engagement Capabilities

Frequently Asked Questions

When does a behavioral health marketing communication require HIPAA authorization?

Any use or disclosure of Protected Health Information (PHI) for marketing purposes requires written authorization, with three specific exceptions: face-to-face communications, promotional gifts of nominal value, and communications about the provider’s own health-related services ^{6, 10}. Data from pre-relationship inquiries is not yet PHI. However, once it becomes part of a clinical record, HIPAA rules apply, and previous consents do not automatically transfer to new platforms or audiences ⁷.

Can a treatment center use patient testimonials in advertising?

Yes, but for a Part 2 program, a HIPAA authorization alone is insufficient. 42 CFR Part 2 mandates its own specific consent for disclosing information that identifies an individual as having received SUD treatment, which is inherent in a testimonial ⁴. Video testimonials, named alumni features, and case studies require Part 2-compliant consent, which differs from a standard media release.

What level of evidence does the FTC expect behind outcome and efficacy claims?

The FTC’s December 2022 Health Products Compliance Guidance requires competent and reliable scientific evidence for health-related claims. This is defined as testing, analysis, or research conducted by qualified individuals using procedures generally accepted in the field ⁹. Internal CRM completion rates, without disclosed methodology, do not meet this standard. Efficacy language must be tied to the specific modality, not broadly applied across an entire program catalog.

Are retargeting pixels and lead-form trackers compatible with 42 CFR Part 2?

Compatibility requires structural changes. A pixel firing on a Part 2 program’s SUD landing pages can transmit identifying interest data to ad platforms, creating disclosure risk even before a treatment relationship is established ⁴. Operational adjustments typically include server-side tagging with stripped identifiers, excluding pages that disclose specific levels of care, and ensuring Business Associate Agreements (BAAs) are explicitly scoped to Part 2, not just HIPAA.

How should Joint Commission accreditation be referenced in marketing materials?

Accreditation should be stated as a dated fact, for example: “accredited by The Joint Commission,” rather than “Joint Commission approved” ³. Avoid visually pairing accreditation logos with outcome claims, as this implies the accrediting body validated those outcomes. Similar caution applies to federal agencies; HHS has clarified that it does not endorse compliance programs, and marketing materials should not suggest otherwise ⁸.

Which metrics should replace impressions and clicks when reporting marketing performance to a CFO?

The 2024 Patient Engagement Impact Measurement Framework structures measurement around access, experience, and clinical outcomes ². For admissions reporting, this translates to metrics such as qualified calls by source, time-to-first-response, call-to-admit rate by source, and cost per admission by service line. Impressions and CPC remain useful for diagnostic purposes, but financial discussions should focus on admissions and census contribution, where budget decisions are made.

References

Growth of Health IT-Enabled Patient Engagement Capabilities among U.S. Hospitals: 2021–2024. https://healthit.gov/data/data-briefs/growth-health-it-enabled-patient-engagement-capabilities-among-us-hospitals-2021/
A Patient Engagement Impact Measurement Framework. https://pmc.ncbi.nlm.nih.gov/articles/PMC11717831/
The Joint Commission. https://www.ncbi.nlm.nih.gov/books/NBK557846/
Substance Use Disorders: Statutes, Regulations, and Guidelines. https://www.samhsa.gov/substance-use/treatment/statutes-regulations-guidelines
Examining Advertising and Marketing Practices within the Substance Use Treatment Industry. https://www.govinfo.gov/content/pkg/CHRG-115hhrg35759/html/CHRG-115hhrg35759.htm
Marketing | HHS.gov (HIPAA Privacy Rule Guidance). https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/marketing/index.html
HIPAA Privacy Rule FAQs: Marketing. https://www.hhs.gov/hipaa/for-professionals/faq/marketing/index.html
HIPAA Guidance Materials | HHS.gov. https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/index.html
FTC Announces New Business Guidance for Marketers and Sellers of Health Products. https://www.ftc.gov/news-events/news/press-releases/2022/12/ftc-announces-new-business-guidance-marketers-sellers-health-products
What are the HIPAA Marketing Rules?. https://www.hipaajournal.com/hipaa-marketing-rules/